ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664W955. A total of 4 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $3,173,000 | -88.9% | 150,000 | -75.8% | 0.03% | -89.3% |
Q4 2018 | $28,538,000 | -41.5% | 620,400 | -43.6% | 0.24% | -40.9% |
Q3 2018 | $48,807,000 | +272.1% | 1,100,000 | +228.7% | 0.41% | +330.2% |
Q2 2018 | $13,117,000 | +271.5% | 334,700 | +234.7% | 0.10% | +123.3% |
Q1 2017 | $3,531,000 | – | 100,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 399 | $3,262,000 | 0.12% |
GROUP ONE TRADING, L.P. | 24,000 | $1,962,000 | 0.03% |
SIMPLEX TRADING, LLC | 221 | $234,000 | 0.02% |
Citadel Advisors | 27,000 | $2,208,000 | 0.00% |